Cargando…
Clinical significance of glypican-3-positive circulating tumor cells of hepatocellular carcinoma patients: A prospective study
The utility of glypican-3 (GPC3) expression for the detection of circulating tumor cells (CTCs) in hepatocellular carcinoma (HCC) patients has not been elucidated. The aim of this study was to identify associations between the presence of GPC3-positive CTCs and clinicopathological factors of these p...
Autores principales: | Hamaoka, Michinori, Kobayashi, Tsuyoshi, Tanaka, Yuka, Mashima, Hiroaki, Ohdan, Hideki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541303/ https://www.ncbi.nlm.nih.gov/pubmed/31141571 http://dx.doi.org/10.1371/journal.pone.0217586 |
Ejemplares similares
-
Verification of inflammation‐based prognostic marker as a prognostic indicator in hepatocellular carcinoma
por: Yamamoto, Masateru, et al.
Publicado: (2019) -
Glypican 3-Targeted Therapy in Hepatocellular Carcinoma
por: Nishida, Takahiro, et al.
Publicado: (2019) -
Prognostic significance of glypican-3 in hepatocellular carcinoma: a meta-analysis
por: Xiao, Wei-Kai, et al.
Publicado: (2014) -
Heterophile carbohydrate antigen N‐glycolylneuraminic acid as a potential biomarker in patients with hepatocellular carcinoma
por: Akimoto, Shuji, et al.
Publicado: (2023) -
Significance of liver resection for intermediate stage hepatocellular carcinoma according to subclassification
por: Yamamoto, Masateru, et al.
Publicado: (2021)